Phosphate-binding polymers for oral administration

Details Phosphate-binding polymers for oral administration Phosphate-binding polymers for oral administration

1995-06-06

1997-09-16

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Ion exchange resin

424 7812, 424 7808, 424 7816, A61K 31785

Patent

active

056677758

ABSTRACT:
Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.

REFERENCES:
patent: 3980770 (1976-09-01), Ingelman et al.
patent: 4181718 (1980-01-01), Mason et al.
patent: 4205064 (1980-05-01), Wagner et al.
patent: 4247393 (1981-01-01), Wallace
Physicians' Desk Reference, Consult 1992 Supplements for Revisions "Phoslo.RTM.", Calcium Acetate Tablets.
Physicians' Desk Reference, Consult 1992 Supplements for Revisions "Amphojel.RTM.", Suspension Tablets.
Burt, et al., "Ion-Exchange Resins as Potential Phosphate-Binding Agents for Renal Failure Patients: Effect of the Physicochemical Properties of Resins on Phosphate and Bile Salt Binding," Journal of Phamaceutical Sciences, 76(5):379-383 (1987).
Delmez, James A. et al., "Hyperphosphatemia: Its Consequences and Treatment in Patients with Chronic Renal Disease," American Journal of Kidney Diseases, XIX(4):303-317 (1992).
Emmett, Michael et al., "Calcium Acetate Control of Serum Phosphorus in Hemodialysis Patients," American Jouranl of Kidney Diseases, XVII(5):544-550 (1991).
Ghosh, J.P. et al., "Preparation and Properties of a New Chelating Resin Containing 2-Nitroso-1-naphthol," Talanta, 28:957-959 (1981).
Mai, Martin L. et al., "Calcium acetate, an effective phosphorus binder in patients with renal failure," Kidney International, 36:690-695 (1989).
Munson, Paul L., "Studies on the Role of the Parathyroids in Calcuim and Phosphorus Metabolism," Annals New York Academy of Sciences, pp. 776-795 (Jun. 1993).
Salusky, I.B. et al., "Aluminum Accumulation During Treatment with Aluminum Hydroxide and Dialysis in Children and Young Adults with Chronic Renal Disease," The New England Journal of Medicine, 324(8):537-531 (1991).
Slatopolsky, Eduardo et al., "Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis," The New England Journal of Medicine, 315(3):157-161 (1986).
Warshawsky, A., in Ion Exchange and Sorption Processes in Hydrometallurgy Critical Reports on Applied Chemistry, vol. 15, Chapter 4: Chelating ion exchangers, pp.166-225 M. Streat & D. Naden (Eds.), John Wiley & Sons, (1987).
Winston, Anthony and Kirchner, Darrell, "Hydroxamic Acid Polymers. Effect of Structure of the Selective Chelation of Iron in Water," Macromolecules, 11(3):597-603 (1978).
Winston, Anthony and McLaughline, Glenn R., "Hydroxamic Acid Polymers. II. Design of a Polymeric Chelating Agent for Iron," Journal of Polymer Science, 14:2155-2165 (1976).
McGary, T.J. et al., "Polycation as an Alternative Osmotic Agent and Phosphate Binder in Peritoneal Dialysis," Uremia Investigation, 8(2):79-84 (1984-1985).

Affiliated with

Also associated with

Rating

Phosphate-binding polymers for oral administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphate-binding polymers for oral administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphate-binding polymers for oral administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-216180